Cannabis ein sicherer mid-bigcap- Hafen?
https://www.bnnbloomberg.ca/commodities/video/...abis-wheaton~1400540
Was sind blue stamps?
Sunny Freeman:
Cannabis Wheaton Income Corp.’s chief executive and marijuana industry pioneer Chuck Rifici admits the intricacies of large private placement deals are not his forte.
But he trusts the Vancouver-based company’s team of legal and banking experts would have flagged any conflict of interest in the controversial $80-million private placement cancelled last Monday amid questions about the personal stakes taken in the deal by some of those very same advisers.
Und laut Deinem eingestellten Video haben those very same advisers total 19 Millionen CAD in die Tasche stecken wollen. Weil es an die Öffentlichkeit durchsickerte machten die Geldgeber einen Rückzug.
Wundert es da, dass Fragen auftauchen wieviele Millionen bei der jetzigen Transaktion in privaten Taschen verschwinden? Rifici ist kein integrer CEO im Gegenteil, er ist ein Gauner, dem bis jetzt nichts angelastet werden kann. Jetzt kann man argumentieren er schaffe für die Aktionäre Mehrwert aber im gleichen Atemzug bestielt er sie auch!
Dies hat nichts mit Kanada zu tun, aber mit dem CEO von Cannabis Wheaton.
Und laut Deinem eingestellten Video haben those very same advisers total 9 -10 Millionen CAD in die Tasche stecken wollen.
Die Verkäufe werden den Kurs nicht beeinflussen, wenn ich das richtig verstehe.
Ich hoffe auf die Stärke der Aktionäre, dass sich alles zum guten wendet. Vielleicht ist auch alles ganz anders. Ich hoffe zu viel...
Ich denke es ist durchaus als Vertrauensbeweis zur verstehen,
wenn die BOM 100 Mio. zahlt.
...leider ist es wieder eine Verwässerung, auf der anderen Seite, mal
sehen was mit dem Geld gemacht wird. Kann durchaus wieder ein
sinnvoller und weiter führender Ankauf anstehen.
VG DEWR
https://www.dropbox.com/s/z9blz0ps5l5eppp/CBW%20AIF.pdf?dl=0
[Quelle: Investor-Group bei Facebook (https://www.facebook.com/groups/cbwinvestors)]
– Quinsam Capital Corporation (CSE:QCA) ("Quinsam" or the "Company") is pleased to announce that it has completed the sale of its position in Dosecann Inc. (“Dosecann”) as part of the takeover of Dosecann by Cannabis Wheaton Income Corp. (“Cannabis Wheaton”).
Roger Dent, CEO of Quinsam said “We are very pleased with the result of our investment in Dosecann and we look forward to its contribution to our Q2/2018 results.”
Quinsam invested $875,000 in Dosecann in early 2018. The investment consisted of a combination of $875,000 of convertible debentures and 437,500 warrants.
In exchange for its investment in Dosecann, Quinsam received 1,092,000 shares of Cannabis Wheaton plus 546,000 warrants in Cannabis Wheaton with an exercise price of $0.962. In addition, Quinsam will receive additional Cannabis Wheaton shares in lieu of the interest owing on the debenture. In aggregate, the value of the securities obtained by Quinsam is well in excess of $2 million at the present time.
In anderen Worten, ein Invest von $875 000 in 4-5 Monaten wertgesteigert auf rund $2 000 000 (+128%)
Aus Deinem Link (Seite 15)
On May 22, 2018 the Company announced that it has entered into an agreement with a syndicate of underwriters, led by BMO Capital Markets, pursuant to which the underwriters have agreed to buy on a bought deal basis, 71 500 000 units of the Company at a price of $ 1.40 per unit, representing aggregate gross proceeds to the Company of approximately $ 100 million. Each unit consist of one common share and one-half of one common share purchase warrant, with each whole common share purchase warrant entitling the holder thereof to purchase one common share at a price of $ 1.85 per common share for a period of 24 months following the closing date.
Und auf dem level CAD 1.40 hat der Kurs seit Bekanntgabe des Deals auch geschlossen (1.39 - 1.40). Die Börse betrachtet den neusten Deal imho doch einigermassen kritisch!
ps, interessante Zusammenfassung über die sehr unübersichtliche CBW
sedar.com/...mpanyDocuments.do?lang=EN&issuerNo=00005865#
Calculating our percentage return for the quarter remains difficult because we closed an equity financing during the period said Roger Dent, CEO of Quinsam. Our operating income of $4.9 million in the quarter was generated on total assets at the start of the quarter of $19.4 million. We raised a further $12.3 million in the quarter, although most of these funds remained in cash at the end of the quarter. So we feel that our return on invested assets was quite strong in the quarter. At quarter end, we had net assets of approximately $0.31 per share outstanding.
Net income of $4.9 million was after non-cash expenses of $0.1 million for tax and $0.3 million for stock-based compensation.
Q2 Outlook
Q2 continues to be on track for a positive result. Of particular note, the Company's $875,000 investment in Dosecann Inc. completed in January 2018 has triggered significant appreciation due to the acquisition of Dosecann Inc. by Cannabis Wheaton Income Corp. at a price which was over twice our effective cost. We have also seen gains on listings by Xanthic Biopharma Inc., Empower Clinics Inc. and Khiron Life Sciences Corp. One of our larger investments (in C21 Investments Inc.) is expected to be trading before the end of the quarter.
We have also announced a plan to sell our right to a 35% stake in Herbiculture Inc. to Lineage Grow Company Ltd. (Lineage) in exchange for 3.9 million shares of Lineage. As we carry this right at no cost, the entire proceeds would be accretive to our NAV on a pre-tax basis. This transaction has not closed but we expect it to do so before the end of Q2/2018 said Roger Dent.
While the cannabis sector has shown and likely will show significant volatility, we still see many extremely interesting investment opportunities said Roger Dent. We will continue to look for opportunities that are generally unavailable to the typical investor. We will also remain focused on maintaining a tight cost structure. By bringing a disciplined approach to this rather volatile sector, we have to date been able to deliver strong results for our investors.
About Quinsam Capital Corporation
Quinsam is a merchant bank based in Canada that is focusing on cannabis-related investments. Our merchant banking business may encompass a range of activities including acquisitions, advisory services, lending activities and portfolio investments. Quinsam invests its capital for its own account in assets, companies or projects which we believe are undervalued and where we see a viable plan for unlocking such value. We do not invest on behalf of any third party and we do not offer investment advice.
Generally, Quinsam does not believe that individual investments are material reportable events. Quinsam chooses to announce certain investments once the company is certain that it has finished buying its position because the Company feels that this information helps Quinsams investors understand its investment decision making process. Generally, Quinsam does not announce the sale of investments.
For further information please contact:
Roger Dent, CEO
(647) 993-5475
roger@quinsamcapital.com